NMC
TEVA icon

Nine Masts Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Nine Masts Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-67,227
Closed -$1.04M – 252
2018
Q4 		$1.04M Buy
67,227
+66,427
+8,303% +$1.36M 0.16% 64
2018
Q3 		$66K Buy
+800
New +$18.6K 0.02% 247
2018
Q2 		– Sell
-56,860
Closed -$1.16M – 370
2018
Q1 		$972K Buy
+56,860
New +$1.11M 0.15% 67

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nine Masts Capital's TEVA Position: Q1 2019 in Review

Nine Masts Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2019, closing a stake of 67,227 shares — an estimated $1.04M sold.

Nine Masts Capital first reported a position in TEVA in Q1 2018 and held it in 3 quarters. The position peaked at $1.04M in Q4 2018. 522 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

  • Nine Masts Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2019 after selling out during the quarter.
  • Nine Masts Capital sold 67,227 Teva Pharmaceutical Industries Limited shares in Q1 2019, an estimated $1.04M.
  • Nine Masts Capital first reported a position in Teva Pharmaceutical Industries Limited in Q1 2018 and held it in 3 quarters.
  • Nine Masts Capital's Teva Pharmaceutical Industries Limited position peaked at $1.04M in Q4 2018.
  • 522 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2019.

Based on Nine Masts Capital's 13F filing for Q1 2019, filed 6 May 2019.